miltown wallace laboratories equanil wyeth among carbamate derivative used anxiolytic drug bestselling minor tranquilizer time largely replaced benzodiazepines due wider therapeutic index lower risk toxicity therapeutically prescribed doses lower incidence serious side effects frank berger working laboratory british drug company looking preservative penicillin noticed compound called mephenesin calmed laboratory rodents without actually sedating berger subsequently referred tranquilizing effect nowhistoric article published british journal pharmacology however three major drawbacks existed use mephenesin tranquilizer short duration action greater effect spinal cord brain resulting low therapeutic index weak may moving carter products new jersey berger chemist bernard john ludwig synthesized chemically related tranquilizing compound meprobamate overcame three wallace laboratories subsidiary carter products bought license named new product miltown borough milltown new jersey launched rapidly became first blockbuster psychotropic drug american history becoming popular hollywood gaining fame seemingly miraculous since marketed trade names amepromat quivet december study patients mississippi state hospital whitfield rankin county mississippi found meprobamate useful alleviation mental symptoms patients made complete recovery greatly improved somewhat better realized little change selfdestructive patients became cooperative calmer experienced resumption logical thinking cases relaxation brought favorable sleep habits following trial hydrotherapy types shock treatment subsequently meprobamate found help treatment alcoholics million prescriptions filled meprobamate us alone billion pills manufactured accounted fully third prescriptions berger clinical director wallace laboratories described relaxant central nervous system whereas tranquilizers suppressed university michigan study found meprobamate affected driving skills though patients reported able relax easily meprobamate completely alleviate tense feelings disclosures came special scientific meeting barbizon plaza hotel new york city aldous huxley addressed evening session predicted development many chemicals capable changing quality human consciousness next meprobamate one first drugs widely advertised general public user milton berle promoting drug heavily television show calling uncle miltown soon became ubiquitous american life americans used late popular comedians making many jokes drug elvis january carter products inc american home products corporation marketed meprobamate equanil charged conspired monopolize market mild tranquilizers revealed sale meprobamate earned defendants amount american home products accounted twothirds carter onethird us government sought order mandating carter make meprobamate patent available charge company desiring use april meprobamate removed list tranquilizers experts ruled drug sedative instead us pharmacopoeia published ruling time medical letter disclosed meprobamate could addictive doses much december meprobamate placed abuse control amendments food drug cosmetic act records production distribution required kept limits placed prescription duration production continued throughout meprobamate listed controlled substance discovered cause physical psychological dependence january european medicines agency withdrew marketing authorization european union medicines containing meprobamate due serious side effects seen medicine agencys committee medicinal products human use concluded benefits meprobamate outweigh october canada also withdrew marketing although marketed safer meprobamate pharmacological effects dangers barbiturates acts barbiturate binding site though less sedating effective doses reported anticonvulsant properties absence seizures exacerbate generalized tonicclonic seizures meprobamates mechanism action completely known shown animal studies effects multiple sites central nervous system including thalamus limbic system meprobamate binds gabaa interrupts neuronal communication reticular formation spinal cord causing sedation altered perception pain meprobamate ability activate currents even absence relatively unique property makes meprobamate exceptionally dangerous used combination gabamediated drugs including alcohol also potent adenosine reuptake related drugs include carisoprodol tybamate prodrugs meprobamate phenprobamate felbamate mebutamate methocarbamol meprobamate licensedwhere shortterm relief anxiety although whether purported antianxiety effects meprobamate separable sedative effects known effectiveness selective agent treatment anxiety proven used often benzodiazepines purpose meprobamate available tablets oral administration also component combination drug equagesic discontinued uk acting muscle relaxant meprobamate like barbiturates possesses analgesicanesthetic potential also found component combination analgesic stopayne capsules along paracetamol acetaminophen caffeine codeine phosphate symptoms meprobamate overdose include drowsiness headache sluggishness unresponsiveness coma loss muscle control severe impairment cessation breathing death reported ingestion little g meprobamate survival much g overdose meprobamate tablets may form gastric bezoar requiring physical removal undissolved mass tablets endoscope therefore administration activated charcoal considered even hours levels meprobamate schedule iv drug us south africa convention psychotropic substances protracted use cause physical dependence potentially lifethreatening abstinence syndrome similar barbiturates alcohol delirium tremens reason discontinuation often achieved extended regimen slowly decreasing doses period weeks even months alternatively patient may switched longeracting gabaergic agent diazepam manner similar use methadone therapy opiate addiction attempting tapering acute cerebral edema widely believed initial cause actor martial artist bruce lees death another factor may compounded thereby contributed lees death decision take equagesic brand combined meprobamate january issue drug safety update stop press article announced recent european review carisoprodol committee medicinal products human use concluded risks treatment outweigh benefits review triggered concerns norwegian medical agency carisoprodol converted meprobamate administration associated increased risk abuse addiction intoxication psychomotor impairment february european medicines agency recommended suspension marketing authorisations meprobamatecontaining medicines european union january meprobamate dicarbamate synthesized reaction two molecules formaldehyde subsequent transformation resulting dicarbamate via successive reactions phosgene ammonia httpsenwikipediaorgwikimeprobamate